Date of Award
8-2026
Document Type
Thesis
Degree Name
Master of Science (MS)
Department
Economics
Committee Chair/Advisor
Devon Gorry
Committee Member
Reed Watson
Committee Member
Thomas Evans
Abstract
Insulin is a life-saving medication for people with diabetes that helps regulate blood glucose levels throughout the body. A Type 1 diabetic cannot survive without insulin, and a Type 2 diabetic’s quality of life greatly diminishes without access and use of this drug. Currently, many diabetics skip, ration, or abstain from insulin due to financial barriers. As of June 2026, 29 states have enacted insulin copayment caps for state-regulated commercial health insurance plans to reduce the financial burden of insulin costs. This study examines the impact of these caps on all commercially insured diabetics in the United States, particularly on overall insulin use and general health and medical care outcomes through a standard two-way fixed effects difference-in-differences model.
The results from the preferred specification indicate statistically significant findings on both overall insulin use and health and medical care outcomes for diabetics in states with these caps. Diabetics in capped states are 2.37 percentage points more likely to utilize insulin than diabetics in states without caps, holding all else constant. Additionally, poor mental health days (per month) decreased by approximately 20%, A1C checks increased by 15.5% (per year), and the probability of a routine checkup increased by 1.21 percentage points. Thus, the findings suggest that cost barriers currently suppress optimal levels of insulin use in states without caps and that the institution of these caps is associated with beneficial outcomes for insulin use, general health, and general medical care outcomes.
Recommended Citation
Meyer, Ryan C., "The Impact of State Insulin Copayment Caps on Diabetics in the United States" (2026). All Theses. 4854.
https://open.clemson.edu/all_theses/4854
Author ORCID Identifier
0009-0003-4327-698X
Included in
Business Commons, Diseases Commons, Econometrics Commons, Health Economics Commons, Medical Education Commons, Multivariate Analysis Commons, Other Economics Commons, Political Economy Commons, Statistical Models Commons